ALZN · ISSUER CIK 1677077
Alzamend Neuro, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Alzamend Neuro, Inc. insiders reported $0.00 of open-market purchases and $3K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$3KInsider selling
−$3KNet open-market
Aug 31, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 202606:05 | Aug 26, 2026 | ALZN | Director | S · SellLate 5d | $1.56 | −2,000 | 0 | -100% | −$3K |